Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Individualized Hybrid Electroconvulsive Therapy (i-HECT) Shows Rapid Anti-Depressant Effect and Improved Cognition in Young Patients with Depression

Jing-ya Zhang, Lun Zeng, Jia Li, View ORCID ProfileMian-mian Chen, View ORCID ProfileShu-xian Xu, Baijian Tan, View ORCID ProfileXin-hui Xie
doi: https://doi.org/10.1101/2024.08.01.24311339
Jing-ya Zhang
aDepartment of Clinical Psychology, Second People’s Hospital of Huizhou, Huizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lun Zeng
aDepartment of Clinical Psychology, Second People’s Hospital of Huizhou, Huizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jia Li
bElectroconvulsive Therapy Room, Second People’s Hospital of Huizhou, Huizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mian-mian Chen
cDepartment of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mian-mian Chen
Shu-xian Xu
cDepartment of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shu-xian Xu
Baijian Tan
aDepartment of Clinical Psychology, Second People’s Hospital of Huizhou, Huizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin-hui Xie
cDepartment of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China
dBrain Function and Psychosomatic Medicine Institute, Second People’s Hospital of Huizhou, Huizhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xin-hui Xie
  • For correspondence: xxh.med{at}gmail.com xin-hui.xie{at}whu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background For young patients with depression, electroconvulsive therapy (ECT) is highly effective but causes acute cognitive side effects. We designed a new i-HECT therapy combines ECT with low-charge electrotherapy (LCE) and individual symptom monitoring to reduce cognitive impairments.

Methods i-HECT comprised two treatments: ECT and LCE. ECT utilized an energy set of 1.5 times the seizure threshold (ST), while LCE was set at 0.5 ST. The initial session employed ECT. Subsequent sessions involved ECT or LCE, depending on whether meeting the ECT-LCE transition criteria (MADRS total score < 22 or ≥ 50% reduction), assessed after each session.

Results The intention-to-treat analysis revealed an 80.4% response rate and a 58.7% remission rate (Hedges’ g = 3.29). Notably, both subjective and objective cognitive functions significantly improved post-i-HECT treatments and during the 3-month follow-up periods.

Conclusion The i-HECT protocol may provide a rapid antidepressant treatment option with cognitive benefits for young depression patients.

Highlights

  • Designed a novel but simple ECT protocol, i-HECT, for young depression patients.

  • The trial employed Simon’s optimal two-stage design with a high power of 0.95.

  • The i-HECT rapidly improved both depression symptoms and cognitive functions.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ChiCTR2100045682

Funding Statement

This work was supported by grant from the Science and Technology Program of Huizhou (Grant No. 2021SC010311001 (Baijian Tan) and 2022CQ010013 (Lun Zeng)) and the Guangdong Medical Research Foundation (Grant No.A2022333 (Lun Zeng)). This work has not received funding/assistance from any commercial organizations. The funding source had no roles in the design of this study and will not have any roles during the execution, analyses, interpretation of the data, or decision to submit results.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This single-arm trial employed a Simon's optimal two-stage design with a 3-month follow-up duration, conducted at the Second People's Hospital of Huizhou in accordance with the Declaration of Helsinki. The Human Ethics Committee of the Hospital approved the protocol. Patients and their legal guardians can withdraw at any time for any reason.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Conflict of Interest The authors declare that there is no conflict of interest in this work.

  • Funding This work was supported by grant from the Science and Technology Program of Huizhou (Grant No. 2021SC010311001 (Baijian Tan) and 2022CQ010013 (Lun Zeng)) and the Guangdong Medical Research Foundation (Grant No.A2022333 (Lun Zeng)). This work has not received funding/assistance from any commercial organizations. The funding source had no roles in the design of this study and will not have any roles during the execution, analyses, interpretation of the data, or decision to submit results.

Data Availability

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 07, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Individualized Hybrid Electroconvulsive Therapy (i-HECT) Shows Rapid Anti-Depressant Effect and Improved Cognition in Young Patients with Depression
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Individualized Hybrid Electroconvulsive Therapy (i-HECT) Shows Rapid Anti-Depressant Effect and Improved Cognition in Young Patients with Depression
Jing-ya Zhang, Lun Zeng, Jia Li, Mian-mian Chen, Shu-xian Xu, Baijian Tan, Xin-hui Xie
medRxiv 2024.08.01.24311339; doi: https://doi.org/10.1101/2024.08.01.24311339
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Individualized Hybrid Electroconvulsive Therapy (i-HECT) Shows Rapid Anti-Depressant Effect and Improved Cognition in Young Patients with Depression
Jing-ya Zhang, Lun Zeng, Jia Li, Mian-mian Chen, Shu-xian Xu, Baijian Tan, Xin-hui Xie
medRxiv 2024.08.01.24311339; doi: https://doi.org/10.1101/2024.08.01.24311339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)